Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Research & Discovery » Proteomics & Protein Research » GeneProt, Serono, Ciphergen, LumiCyte, Diagnostic Products, Compugen, MelTec, Fraunhofer Institute, Syn X Pharma, Biacore

GeneProt, Serono, Ciphergen, LumiCyte, Diagnostic Products, Compugen, MelTec, Fraunhofer Institute, Syn X Pharma, Biacore

Jan 27, 2003
Premium

GeneProt Offers Proteins to Serono for Testing and Licensing

Last week, GeneProt of Geneva announced an agreement with Geneva-based biopharmaceutical firm Serono that might lead to a licensing deal for GeneProt’s proteins.

Under the agreement, which will initially last for one year, Serono will receive a set of less than 50 synthesized polypeptides and proteins from GeneProt to test using its screening platform. The company then has an option to license the proteins exclusively.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

More to Mix and Match

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

National Academy of Sciences May Expel Members

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

Nucleic Acids Research Papers on DNA-Bound Proteins, Transcriptional Activation, More

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

Pause Recommended

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

Apr
20
Featured Webinar

Analysis of a Wellness Cohort Identifies Markers of Metastatic Cancer Years Prior to Diagnosis

Sponsored by
Olink

This webinar will discuss a study that sought to identify early biomarkers for cancer by analyzing pre-diagnosis samples from seemingly healthy individuals who were later diagnosed with cancer.

Apr
23
Featured Webinar

Advances in Single-Cell Proteomics: Building a Complete Picture of Cellular Identity

Sponsored by
Isoplexis

Recent advances in single-cell technologies have provided unprecedented -omic-level insights into cellular heterogeneity and function. 

May
10
Featured Webinar

Predicting COVID-19 Severity: Leveraging the Host Immune Response to Identify High-Risk Patients and Improve Outcomes

Sponsored by
MeMed

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

May
20
Featured Webinar

Using Spatial Transcriptomics to Understand the Molecular Mechanisms of Memory

Sponsored by
ACD

This webinar will present a research project that is using spatial transcriptomics to discern the molecular mechanisms underlying fear memory.  

What's Popular?

In Proteomics & Protein Research

  1. ImmunoScape Closes $14M Funding Round

  2. Biognosys, Siemens Healthineers Partner for Protein Biomarker Development

  3. Proteomic Study of SARS-CoV-2, SARS-CoV Infections Points to Potential Drug Targets

  4. Proteome-Wide Association Study of Depression Homes in on Potential Treatment Targets

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.